Didier Coeurnelle, Co-chair at Heales (Healthy Life Extension Society) and member of the board at the International Longevity Alliance, discusses developments in longevity research, promoters and barriers to healthy aging, and the importance of preventative approaches to care.
The European Union is to invest around €1.1 billion to numerous innovative projects under the Innovation Fund, as an endeavour towards reaching net zero emissions.
As COP26 reaches its completion in Glasgow this year, the UK pledges for more urgent action and investment protecting land, nature, and oceans on their respective summit days. Here’s the breakdown.
Her Excellency Huda Al Hashimi, Deputy Minister of Cabinet Affairs for Strategic Affairs - UAE Government, provides commentary on a new hub for public sector pilots around the world, under the Moonshot Pilot Grant.
Sarah Woolnough, CEO of Asthma UK and the British Lung Foundation, reflects on landmark research undertaken by the charity ahead of World COPD Day, including the largest ever survey of people with COPD in the UK.
New research finds that climate change affecting the Amazon rainforest has also developed issues with its bird species, adjusting the body and wing length of resident birds.
A new low carbon locomotive design launched by Nuclear Transport Solutions’ (NTS) rail division is to be presented at this year’s Low Carbon Logistics event in Mossend, Scotland.
In the second part of a series of articles, shortages in medicolegal death investigation are placed under the spotlight by Victor W. Weedn, MD, JD, Chief Medical Examiner at Maryland Office of the Chief Medical Examiner.
L. Val Giddings, PhD, Senior Fellow, Information Technology and Innovation Foundation, states that gene editing promises to make human industry sustainable*.
The Safety of Women at Night Fund will award up to £5 million to organisations looking to protect women in public spaces at night through safety initiatives.
A new potential treatment and vaccine for Alzheimer’s disease has been developed by a team of UK and German scientists, using a different approach with amyloid beta protein.
